FNBOSM
TEVA icon

First National Bank of South Miami’s Teva Pharmaceuticals TEVA Stock Holding History

First National Bank of South Miami’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,500
Closed -$43K – 298
2020
Q2 		$43K Hold
3,500
– – 0.05% 169
2020
Q1 		$31K Buy
+3,500
New +$35.9K 0.04% 177

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

First National Bank of South Miami's TEVA Position: Q3 2020 in Review

First National Bank of South Miami sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 3,500 shares — an estimated $43K sold.

First National Bank of South Miami first reported a position in TEVA in Q1 2020 and held it in 2 quarters. The position peaked at $43K in Q2 2020. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • First National Bank of South Miami reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • First National Bank of South Miami sold 3,500 Teva Pharmaceuticals shares in Q3 2020, an estimated $43K.
  • First National Bank of South Miami first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • First National Bank of South Miami's Teva Pharmaceuticals position peaked at $43K in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on First National Bank of South Miami's 13F filing for Q3 2020, filed 16 Nov 2020.